These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17484228)

  • 81. Extensive and recalcitrant verrucae vulgares of the great toe treated with imiquimod 5% cream.
    Atzori L; Pinna AL; Ferreli C
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):366-7. PubMed ID: 12702097
    [No Abstract]   [Full Text] [Related]  

  • 82. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
    Schöfer H; Tatti S; Lynde CW; Skerlev M; Hercogová J; Rotaru M; Ballesteros J; Calzavara-Pinton P
    Int J STD AIDS; 2017 Dec; 28(14):1433-1443. PubMed ID: 28566057
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts.
    Stefanaki C; Katzouranis I; Lagogianni E; Hadjivassiliou M; Nicolaidou E; Panagiotopoulos A; Anyfantakis V; Bethimoutis G; Rallis E; Antoniou C; Katsambas A
    Int J STD AIDS; 2008 Jul; 19(7):441-4. PubMed ID: 18574113
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Imiquimod as a dermatological therapy.
    Tran H; Moreno G; Shumack S
    Expert Opin Pharmacother; 2004 Feb; 5(2):427-38. PubMed ID: 14996638
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Topical imiquimod.
    Pearson GW; Langley RG
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Successful treatment of recurrent and refractory cervical condylomata acuminata with topical 5% imiquimod cream in five patients.
    Ma CG; Chen MK; Yang SC; Bai S; Liao QM
    Int J STD AIDS; 2010 Jul; 21(7):528-9. PubMed ID: 20852209
    [No Abstract]   [Full Text] [Related]  

  • 87. [Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
    Protasov AD; Lipatov IS; Kostinov MP; Tezikov YV; Shmitko AD; Pakhomov DV; Blagovidov DA; Zhestkov AV; Ryzhov AA; Vekhova EV
    Urologiia; 2016 Nov; (5):47-51. PubMed ID: 28248020
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
    Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
    Gollnick H; Barasso R; Jappe U; Ward K; Eul A; Carey-Yard M; Milde K
    Int J STD AIDS; 2001 Jan; 12(1):22-8. PubMed ID: 11177478
    [TBL] [Abstract][Full Text] [Related]  

  • 90. To cut a long story short - the use of imiquimod in resistant warts.
    Murray C
    Int J STD AIDS; 2002 Apr; 13(4):275-6. PubMed ID: 11886616
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata.
    Dede M; Kubar A; Yenen MC; Alanbay I; Guven S; Mesten Z; Baser I
    Acta Obstet Gynecol Scand; 2007; 86(8):968-72. PubMed ID: 17653883
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
    Oster-Schmidt C
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Treatment of recalcitrant plantar warts with imiquimod.
    Yesudian PD; Parslew RA
    J Dermatolog Treat; 2002 Mar; 13(1):31-3. PubMed ID: 12006136
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The importance of patient and healthcare provider perceptions in the evaluation of imiquimod and other prior treatments for anogenital warts.
    Nelson AL
    Int J STD AIDS; 2002 Jan; 13(1):29-35. PubMed ID: 11802927
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Condylomata acuminata in children.
    Stefanaki C; Barkas G; Valari M; Bethimoutis G; Nicolaidou E; Vosynioti V; Kontochristopoulos G; Papadogeorgaki H; Verra P; Katsarou A
    Pediatr Infect Dis J; 2012 Apr; 31(4):422-4. PubMed ID: 22189529
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis.
    Gotovtseva EP; Kapadia AS; Smolensky MH; Lairson DR
    Sex Transm Dis; 2008 Apr; 35(4):346-51. PubMed ID: 18360317
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
    Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
    Hengge UR; Cusini M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A review of imiquimod 5% cream for the treatment of various dermatological conditions.
    Salasche S; Shumack S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():1-3. PubMed ID: 14616801
    [No Abstract]   [Full Text] [Related]  

  • 100. Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%.
    Murua AA; González LC; García-Río I; Urra IT; Michelena IA; González-Pérez R; Santarén BC; Arechavala RS
    Int J Dermatol; 2008 Dec; 47(12):1334-6. PubMed ID: 19126041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.